Cytogel Pharma, LLC

Amendment

CIK: 0001491841·Pharmaceuticals·CONNECTICUT·Filed: Dec 23, 2025

Total Offering

$1,000,000

Amount Sold

$250,000

Investors

3

First Sale

Oct 14, 2025

Offering Details

Type: Debt, Option to Acquire
Exemptions: Rule 506(b)

Related Persons

Name	Role
C. Dean Maglaris	Executive Officer, Director
Jerry P. Leamon	Director
Cassandra Klimp	Director
Frederick W. Telling	Executive Officer, Director
Steven Chrust	Director
Michael Ullmann	Director
Eric Lang	Director
Theodore Maione	Executive Officer

Company

Cytogel Pharma, LLC

3 THORNDAL CIRCLE

DARIEN, CT, 06820

203-966-9867

SEC Filing

0001213900-25-125022

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.